title: Management of peritoneal surface malignancy: a review of the recent literature.
abstract: Peritoneal carcinomatosis (PC) is a condition that has been associated with poor outcomes and up until recently was considered a terminal condition. However, recent data suggest that cytoreductive surgery (CRS) and the administration of hyperthermic intraperitoneal chemotherapy (HIPEC) is an effective therapeutic approach. This paper is a review of the recent literature regarding this issue.
authors.affiliation: 1Surgical Clinic, Peritoneal Surface Malignancy Unit, IASO General Hospital, Athens, Greece.
authors.forename: Evgenia
authors.initials: E
authors.lastname: Halkia
authors.forename: Stylianos
authors.initials: S
authors.lastname: Gavriel
authors.forename: John
authors.initials: J
authors.lastname: Spiliotis
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D000077216:Carcinoma, Ovarian Epithelial; D015179:Colorectal Neoplasms / Q000628:therapy; D006801:Humans; D006979:Hyperthermia, Induced; D007274:Injections, Intraperitoneal; D008654:Mesothelioma / Q000628:therapy; D009375:Neoplasms, Glandular and Epithelial / Q000628:therapy; D010051:Ovarian Neoplasms / Q000628:therapy; D010534:Peritoneal Neoplasms / Q000628:therapy*; D011553:Pseudomyxoma Peritonei / Q000628:therapy; D011788:Quality of Life
chemical_list: D000970:Antineoplastic Agents